New report details the 3 trillion euro cost of Europe's anti-science stance on new genomic techniques
The report further projects that this could compound to over €3 trillion over a decade.
- The report further projects that this could compound to over €3 trillion over a decade.
- Dr Sheila Ochugboju, director of the Alliance for Science, commented: "This report details the high cost of saying no to scientific innovations.
- The report discusses the scientific community's concern regarding the EU's position on NGTs, especially in light of the global advancements in bioeconomy.
- In its conclusion the report underscores the economic considerations for the EU surrounding the adoption or non-adoption of NGTs.